News Focus
News Focus
icon url

X Master

04/02/23 11:47 PM

#582565 RE: SkyLimit2022 #580484

This is the best news Merck has had in a long time. I will be listening to see what they say.
Bullish
Bullish
icon url

jammy32

04/03/23 8:13 AM

#582595 RE: SkyLimit2022 #580484

All this good news is keeping the stock at such a low price. Guess the promise of tomorrow is what keeps this board busy. How many tomorrow’s until there are none of us left. How old is Linda powers ?

If this stock was worth more, it would worth more. Geeeeez
icon url

X Master

04/10/23 12:31 PM

#584075 RE: SkyLimit2022 #580484

Merck's CEO and LP?
Bullish
Bullish
icon url

HyGro

04/22/23 1:22 AM

#587943 RE: SkyLimit2022 #580484

Combo trial for recurrent GBM requires a significant resection to qualify for the trial which significantly improve the odds of survival versus the DCVax-L P3 recurrent GBM arm did not have a resection. Not going to be comparable data.